Delhi records 1,245 new COVID-19 cases, one death; positivity rate 7.36%

The daily count of coronavirus cases also breached the 1,000 mark for the third consecutive day, while the positivity rate in the city was above five percent for the seventh day in a row.

Moneycontrol News

July 29, 2022 / 10:46 PM IST

Representative image

Delhi recorded 1,245 fresh COVID-19 cases on July 29, the highest single-day rise in over a month, with a positivity rate of 7.36 percent while one more person succumbed to the viral disease, according to data shared by the health department here. The daily count of coronavirus cases also breached the 1,000 mark for the third consecutive day, while the positivity rate in the city was above five percent for the seventh day in a row.

Delhi had recorded 1,128 COVID-19 cases on Thursday with a positivity rate of 6.56 percent, and zero death. With the fresh infections, the Covid case tally in the national capital rose to 19,53,175, while the death toll rose to 26,308. A total of 16,924 tests were conducted the previous day to detect COVID-19.

Delhi currently has 3,844 active cases, up from 3,526 the previous day. As many as 2,355 COVID-19 patients are in home isolation. The city had seen 1,891 cases on June 26, according to official data.

The national capital on June 15 had recorded 1,375 Covid cases, while the positivity rate was 7.01 percent. On June 14, it had logged 1,118 cases and two deaths, while the positivity rate was at 6.50 percent. Delhi on Wednesday logged 1,066 fresh COVID-19 cases with a positivity rate of 6.91 percent along with two fatalities. The day before, it had reported 781 fresh cases with a positivity rate of 6.40 percent along with two fatalities.

The city on Monday had logged 463 cases and two fatalities as the positivity rate climbed to 8.18 percent, the highest in over a month, according to the Delhi health department data. It had recorded 1,109 cases with a positivity rate of 5.87 percent and one fatality on June 29. Delhi had reported 1,422 cases and zero fatality on May 8, while the positivity rate was recorded at 5.34 percent.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show